| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Common variants in KCNN3 are associated with lone atrial fibrillation.
|
Nat Genet
|
2010
|
3.97
|
|
2
|
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry.
|
Nat Genet
|
2009
|
3.80
|
|
3
|
Genome-wide association study of PR interval.
|
Nat Genet
|
2010
|
3.73
|
|
4
|
Meta-analysis identifies six new susceptibility loci for atrial fibrillation.
|
Nat Genet
|
2012
|
3.71
|
|
5
|
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
|
Lancet
|
2013
|
3.21
|
|
6
|
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.
|
J Am Heart Assoc
|
2013
|
2.47
|
|
7
|
Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing.
|
Chest
|
2008
|
2.39
|
|
8
|
P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study).
|
Am J Cardiol
|
2011
|
2.39
|
|
9
|
Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.
|
Circulation
|
2011
|
2.36
|
|
10
|
European ancestry as a risk factor for atrial fibrillation in African Americans.
|
Circulation
|
2010
|
1.90
|
|
11
|
Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.
|
Heart Rhythm
|
2011
|
1.85
|
|
12
|
Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.
|
Circulation
|
2012
|
1.67
|
|
13
|
Lack of replication in polymorphisms reported to be associated with atrial fibrillation.
|
Heart Rhythm
|
2010
|
1.58
|
|
14
|
Genome-wide association studies of the PR interval in African Americans.
|
PLoS Genet
|
2011
|
1.53
|
|
15
|
Genome-wide association studies in cardiac electrophysiology: recent discoveries and implications for clinical practice.
|
Heart Rhythm
|
2010
|
1.45
|
|
16
|
CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.
|
Pharmacogenomics
|
2009
|
1.37
|
|
17
|
White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study).
|
Am J Cardiol
|
2011
|
1.22
|
|
18
|
Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.
|
Circulation
|
2012
|
1.17
|
|
19
|
Dietary factors and incident atrial fibrillation: the Framingham Heart Study.
|
Am J Clin Nutr
|
2010
|
1.15
|
|
20
|
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation.
|
Circulation
|
2014
|
1.11
|
|
21
|
A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.09
|
|
22
|
Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project.
|
Circ Cardiovasc Genet
|
2011
|
1.06
|
|
23
|
Novel loci associated with PR interval in a genome-wide association study of 10 African American cohorts.
|
Circ Cardiovasc Genet
|
2012
|
0.97
|
|
24
|
Monogenic atrial fibrillation as pathophysiological paradigms.
|
Cardiovasc Res
|
2010
|
0.94
|
|
25
|
Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study.
|
Am Heart J
|
2011
|
0.94
|
|
26
|
Risk assessment for incident heart failure in individuals with atrial fibrillation.
|
Eur J Heart Fail
|
2013
|
0.94
|
|
27
|
Vitamin D status is not related to development of atrial fibrillation in the community.
|
Am Heart J
|
2011
|
0.89
|
|
28
|
A novel clinical prediction rule for 30-day mortality following balloon aortic valuloplasty: the CRRAC the AV score.
|
Catheter Cardiovasc Interv
|
2011
|
0.87
|
|
29
|
Increased perforation risk with an MRI-conditional pacing lead: a single-center study.
|
Pacing Clin Electrophysiol
|
2014
|
0.86
|
|
30
|
P-wave indices: derivation of reference values from the Framingham Heart Study.
|
Ann Noninvasive Electrocardiol
|
2010
|
0.86
|
|
31
|
Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
|
Pharmacogenomics
|
2014
|
0.86
|
|
32
|
Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association.
|
Circulation
|
2016
|
0.86
|
|
33
|
New-onset atrial fibrillation during hospitalization.
|
J Am Coll Cardiol
|
2014
|
0.85
|
|
34
|
Reciprocal relations between physical disability, subjective health, and atrial fibrillation: the Framingham Heart Study.
|
Am Heart J
|
2013
|
0.85
|
|
35
|
Evaluation of non-synonymous NPPA single nucleotide polymorphisms in atrial fibrillation.
|
Europace
|
2010
|
0.84
|
|
36
|
Insulin resistance and atrial fibrillation (from the Framingham Heart Study).
|
Am J Cardiol
|
2011
|
0.83
|
|
37
|
Elevation of parathyroid hormone levels in atrial fibrillation.
|
J Am Coll Cardiol
|
2011
|
0.83
|
|
38
|
Age of natural menopause and atrial fibrillation: the Framingham Heart Study.
|
Am Heart J
|
2012
|
0.83
|
|
39
|
Genomic risk scores in atrial fibrillation: predicting the unpredictable?
|
Eur Heart J
|
2013
|
0.83
|
|
40
|
Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU.
|
Pharmacogenomics
|
2011
|
0.81
|
|
41
|
Sequencing of SCN5A identifies rare and common variants associated with cardiac conduction: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.
|
Circ Cardiovasc Genet
|
2014
|
0.81
|
|
42
|
Genetic loci associated with atrial fibrillation: relation to left atrial structure in the Framingham Heart Study.
|
J Am Heart Assoc
|
2014
|
0.78
|
|
43
|
Genetic etiology and evaluation of sudden cardiac death.
|
Curr Cardiol Rep
|
2013
|
0.76
|
|
44
|
A common connexion between gap junctions, single nucleotide polymorphisms, and atrial fibrillation?
|
Can J Cardiol
|
2012
|
0.76
|
|
45
|
Genetic susceptibility to atrial fibrillation: does heart failure change our perspective?
|
Eur J Heart Fail
|
2013
|
0.75
|
|
46
|
A "Malignant" Arrhythmia: Cardiac Metastasis and Ventricular Tachycardia.
|
Tex Heart Inst J
|
2016
|
0.75
|
|
47
|
Warfarin pharmacogenetics: a controlled dose-response study in healthy subjects.
|
Vasc Med
|
2013
|
0.75
|
|
48
|
Fifteen Genetic Loci Associated With the Electrocardiographic P Wave.
|
Circ Cardiovasc Genet
|
2017
|
0.75
|
|
49
|
Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.
|
Nat Genet
|
2017
|
0.75
|
|
50
|
Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk.
|
Nat Commun
|
2017
|
0.75
|
|
51
|
Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator?
|
Circulation
|
2011
|
0.75
|